Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients

Koji Kurose, Yoshihiro Ohue, Hisashi Wada, +13

Clinical Cancer Research

T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.

Akiko Uenaka, Hisashi Wada, Midori Isobe, +18

PubMed

T-regulatory CellImmunologyImmunoeditingPathologyAntigen Processing +19

A phase I study of vaccination with NY‐ESO‐1f peptide mixed with Picibanil OK‐432 and Montanide ISA‐51 in patients with cancers expressing the NY‐ESO‐1 antigen

Kazuhiro Kakimi, Midori Isobe, Akiko Uenaka, +17

International Journal of Cancer

Esophageal CancerImmunodeficienciesImmunologyImmunodominanceImmunotherapeutics +22

Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients

Ryohei Kawabata, Hisashi Wada, Midori Isobe, +17

International Journal of Cancer

VaccinationCancer ImmunosurveillanceVaccine DevelopmentAutoimmune DiseaseVaccine Research +13

Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)

Koji Kurose, Yoshihiro Ohue, Eiichi Sato, +7

Journal of Thoracic Oncology

Cancer ImmunosurveillanceOncogenic AgentImmunologyRegulatory T CellsActivated Treg +7

Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells

Yoshihiro Ohue, Koji Kurose, Ryohei Nozawa, +8

Cancer Immunology Research

ImmunologyImmunoeditingPathologyTumor-infiltrating T CellsTumor Cells +15

Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination

Hisashi Wada, Eiichi Sato, Akiko Uenaka, +16

International Journal of Cancer

Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient

Kazuhide Tsuji, T Hamada, Akiko Uenaka, +12

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceAutoimmune DiseaseAllergyMedicineMelanoma +12

Heteroclitic serological response in esophageal and prostate cancer patients after NY‐ESO‐1 protein vaccination

Junji Kawada, Hisashi Wada, Midori Isobe, +19

International Journal of Cancer

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC

Yoshihiro Ohue, Koji Kurose, Takahiro Karasaki, +16

Journal of Thoracic Oncology